Foghorn Therapeutics Inc.·4

Oct 29, 5:01 PM ET

DECICCO CARL 4

4 · Foghorn Therapeutics Inc. · Filed Oct 29, 2020

Insider Transaction Report

Form 4
Period: 2020-10-27
DECICCO CARL
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2020-10-27$16.00/sh+5,500$88,000258,397 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION